Article Text

Download PDFPDF

Letter
Authors' response
Free
  1. N Sigurs1,
  2. F Aljassim2,3,
  3. B Kjellman4,
  4. P D Robinson5,6,
  5. F Sigurbergsson7,
  6. R Bjarnason8,
  7. P M Gustafsson2,4,9
  1. 1Department of Paediatrics, Borås Central Hospital, Borås, Sweden
  2. 2Queen Silvia Children's Hospital, Göteborg, Sweden
  3. 3Department of Paediatrics, Alwasl Hospital, Dubai Health Authority, Government of Dubai, UAE
  4. 4Department of Paediatrics, Central Hospital, Skövde, Sweden
  5. 5Department of Respiratory Medicine, The Children's Hospital at Westmead, Australia
  6. 6The Children's Hospital at Westmead Clinical School, Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Australia
  7. 7Emergency Department, Landspitali University Hospital, Reykjavik, Iceland
  8. 8University of Iceland, Department of Paediatrics, Landspitali University Hospital Iceland, Reykjavik, Iceland
  9. 9The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
  1. Correspondence to N Sigurs, Pediatric Department, Borås Hospital, Borås S-50182, Sweden; nele.sigurs{at}vgregion.se

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank Dr Hyvärinen and colleagues for their insightful comments on our recent paper on asthma and allergy outcome at age 18 years after severe respiratory syncytial virus (RSV) bronchiolitis during the first year of life1 and for their contribution of as yet unpublished findings from their 18-year follow-up of the Finnish cohort.2 Their data, obtained in subjects previously hospitalised with bronchiolitis in …

View Full Text

Linked Articles